We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

DIASYS DIAGNOSTIC SYSTEMS

Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App





Diasys Launches New SARS-CoV-2 UTAB FS Universally Applicable Total Antibody Test

By LabMedica International staff writers
Posted on 02 Mar 2021
DiaSys Diagnostic Systems GmbH (Holzheim, Germany) has launched a new immunoturbidimetric test for the quantitative determination of total antibodies in COVID-19.

The universally applicable total antibody test, called SARS-CoV-2 UTAB FS (UTAB = Universal Total AntiBody), allows to detect whether a person has already been infected with SARS CoV-2 and may have developed immunity to the corona virus. More...
The test detects antibodies of the early immune response (IgM and IgA antibodies) as well as antibodies that evoke a more long-lasting specific immune response in blood (antibody class IgG). The SARS-CoV-2 UTAB FS test for clinical diagnostic laboratories provides reliable and indicative results for patient management within only 10 minutes. The test requires no special equipment and allows comparable results on nearly all clinical chemistry analyzers available worldwide.

It is scientifically proven that the virus attaches to the host cell via a special binding site in the spike 1 envelope protein, the so-called receptor binding domain, or RBD for short, and then infects the host cell. Antibodies against this RBD are able to suppress the attachment of the virus to the host cell and thus its infection and are consequently called neutralizing antibodies. Due to the importance of these antibodies, DiaSys has selected the RBD as the target antigen for the assay to determine total antibodies in COVID-19.

Quantitative assessment of antibodies against the RBD domain of the spike protein, so-called anti-RBD SARS-CoV-2 antibodies, is becoming increasingly important. It provides information on the actual spread of infection in the population and enables characterization of a vaccine-induced immune response. It allows to define the initial antibody status, captures the change in antibody levels induced by a vaccine, and permits to judge the efficacy of a vaccine and to determine required vaccination intervals.



Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Portable Electronic Pipette
Mini 96
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study has linked blood proteins to Alzheimer’s disease and memory loss (Photo courtesy of Shutterstock)

Blood Test Could Detect Proteins Linked to Alzheimer's Disease and Memory Loss

Alzheimer’s disease has long been associated with sticky amyloid plaques in the brain, but these markers alone do not fully explain the memory loss and cognitive decline patients experience.... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.